Synthesis and antibacterial studies of chloramphenicol loaded nano-silver against salmonella typhi

Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry

Volumn 39, Issue 2, 2009, Pages 65-72

  Patil, Sharvil S ^a,b   Dhumal, Ravindra S ^b   Varghese, Mithun V ^a,b   Paradkar, A R ^b   Khanna, P K ^a  

^a CENTRE FOR MATERIALS FOR ELECTRONICS TECHNOLOGY C MET   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Chloramphenicol; Resistance; Silver nanoparticles; Typhoid

Indexed keywords

EID: 62349109719     PISSN: 15533174     EISSN: 15533182     Source Type: Journal    
DOI: 10.1080/15533170902762587     Document Type: Article

References (38)

1. QingShan,W., Jian, J., JinHong, F., and JiaCong, S. Norvancomycin-capped silver nanoparticles: synthesis and antibacterial activities against E. coli. Sci. China B Chem., 2007, 50, 418-424.
2. Oloffs, A., Crosse-Siestrup, C., Bisson, S., Rinck, M., Rudolvh, R., and Gross, U. Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron® material. Biomaterials, 1994, 15, 753-758.
3. Tokumaru, T., Shimizu, Y., and Fox, C. Antiviral activities of silver sulfadiazine and ocular infection. Res. Comm. Chem. Pathol. Pharmacol., 1984, 8, 151-158.
4. Paknikar, K. Antimicrobial Activity of Biologically Stabilized Silver Nanoparticles, US Patent no. US2007/0218555A1, 2007.
5. Dibrov, P., Dzioba, J., Khoosheh, K., and Hase, C. Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholera. J. Antimicrob. Agents Chemother., 2002, 46(8), 2668-2670.
6. Shahverdi, A., Fakhimi, A., Shahverdi, H., and Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine, 2007, 3, 168-171.
7. Suvorova, E., Klechkovskaya, V., Kopeikin, V., and Buffat, P. Stability of Ag nanoparticles dispersed in amphiphilic organicmatrix. J. Cryst. Growth, 2005, 275, e2351-e2356.
8. Pal, S., Tak,Y., and Song, J. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle?Astudy of theGram-negative bacterium Escherichia coli. Appl. Environ. Microbiol., 2007, 73(6), 1712-1720.
9. Sondi, I., and Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci., 2004, 275, 177-182.
10. Lok, C., Ho, C., Chen, R., He, Q., Yu, W., Sun, H., Tam, P., Chiu, J., and Che, C. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res., 2006, 5, 916-924.
11. U.S. Environmental Protection Agency. Silver (CASRN 7440-22-4). Available at: http://www.epa.gov/NCEA/iris/subst/0099.htm (accessed January 7, 2008).
12. Chen, X., and Schluesener, H. Nanosilver: a nanoproduct in medical application. Toxicol. Lett., 2008, 176, 1-12.
13. Sergeev, B., Kiryukhin, M., Rubtsova, M., and Prusov, A. Synthesis of protein A conjugates with silver nanoparticles. Colloid J., 2003, 65(5), 636-638.
14. Yakutik, I., and Shevchenko, G. Self-organization of silver nanoparticles forming on chemical reduction to give monodisperse spheres. Surface Sci., 2004, 566(1), 414-418.
15. Kasuga, N., Sato, M., Amano, A., Hara, A., Tsuruta, S., Sugie, A., and Nomiya, K. Light-stable and antimicrobial active silver(I) complexes composed of triphenylphosphine and amino acid ligands: synthesis, crystal structure, and antimicrobial activity of silver(I) complexes constructed with hard and soft donor atoms (n∞{[Ag(L)(PPh3)]2} with L= α-ala-or asn- and n = 1 or 2). Inorg. Chim. Acta, 2008, 361(5), 1267-1273.
16. Khanna, P. K., Singh, N., Kulkarni, D., Deshmukh, S., Charan, S., and Adhyapak, P. Water based simple synthesis of re-dispersible silver nanoparticles. Mater. Lett., 2007, 61, 3366-3370.
17. Shin, H., Yang, H., Kim, S., and Lee, M. Mechanism of growth of colloidal silver nanoparticles stabilized by polyvinyl pyrrolidone in γ -irradiated silver. J. Colloid Interface Sci., 2004, 274(1), 89-94.
18. Temgire, M., and Joshi, S. Optical and structural studies of silver nanoparticles. Rad. Phys. Chem., 2004, 71, 1039-1044.
19. Khanna, P. K., Singh, N., Charan, S., Subbarao, V., Gokhale, R., and Mulik, U. Synthesis and characterization of Ag/PVA nanocomposite by chemical reduction method. Mater. Chem. Phys., 2005, 93, 117-121.
20. Khanna, P. K., Gokhale, R., and Subbarao, V. Poly(vinyl pyrolidone) coated silver nano powder via displacement reaction. J. Mater. Sci., 2004, 39, 3773-3776.
21. Lim, P., Liu, R., She, P.,Hung, C., and Shih,H. Synthesis ofAg nanospheres particles in ethylene glycol by electrochemical-assisted polyol process. Chem. Phys. Lett., 2006, 420, 304-308.
22. World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever. Available at: http://www.who.int/vaccines- documents. (Accessed March 16, 2008)
23. Mandal, S., Mandal, M., and Pal, N. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar typhi. Ind. J. Med. Sci., 2004, 58(1), 16-22.
24. Maza, L., Miller, S., and Ferrarol, M. Use of commercially available rapid chloramphenicol acetyltransferase test to detect resistance in Salmonella species. J. Clin. Microbiol., 1990, 28(8), 1867-1869.
25. Chun, D., Seol, S., Cho, D., and Tak, R. Drug resistance and R plasmids in Salmonella typhi isolated in Korea. J. Antimicrob. Agents Chemother., 1977, 11(2), 209-213.
26. Misra, R., Bawa, K., Magu, S., Bhandari, S., and Menon, P. Outbreak of multi-drug resistant Salmonella typhi enteric fever in Mumbai Garrison. MJAFI, 2005, 61, 148-150.
27. Rang, H., Dale, M., and Ritter, J. Basic Principles of Chemotherapy Pharmacology, 5th ed., Bath Press: London, UK, 2003 Section 5, 631-632.
28. Kibbe,A. Handbook of Pharmaceutical Excipients, 3rd ed., American Pharmaceutical Association and Pharmaceutical Press: London, UK, 2003, 433-439.
29. Paradkar, A., Ambike, A., Jadhav, B., and Mahadik, K. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int. J. Pharm., 2004, 271, 281-286.
30. Ambike, A., Mahadik, K., and Paradkar, A. Stability study of amorphous valdecoxib. Int. J. Pharm., 2004, 282, 151-162.
31. Brause, R., Moeltgen, H., and Kleinermanns, K. Characterization of laserablated and chemically reduced silver colloids in aqueous solution by UV/VIS spectroscopy and STM/SEM microscopy. Appl. Phys. B, 2002, 75, 711-716.
32. Yin, B.,Ma, H.,Wang, S., and Chen, S. Electrochemical synthesis of silver nanoparticles under protection of poly(N-vinylpyrrolidone). J. Phys. Chem. B, 2003, 107, 8898-8904.
33. Charan, S., Singh, N., Khanna, P. K., and Patil, K. R. Direct synthesis of nanocrystalline silver from the reaction between silver carboxylates and n-trioctylphosphine. J. Nanosci. Nanotechnol., 2006, 6, 2095-2102.
34. Khanna, P. K., Kulkarni, D., and Beri, R. K. Synthesis and characterization of myristic acid capped silver nanoparticles. Journal of Nanoparticle Research, 2008, 10, 1059-1062.
35. Kim, J. Antibacterial activity of Ag+ ion containing silver nanoparticles prepared using the alcohol reduction method. J. Ind. Eng. Chem., 2007, 13(4), 718-722.
36. Wang, H., Qiao, X., Chen, J., Wang, X., and Ding, S. Mechanisms of PVP in the preparation of silver nanoparticles. Mater. Chem. Phys., 2005, 94, 449-453.
37. Matthew, A., and Wikler, M. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, 7th ed., Clinical and Laboratory Standards Institute: Pennsylvania, USA, 2006.
38. Dubey, S., Sharma, A., Narain, U., and Pati, U. Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur. J. Med. Chem., 2008, 43(9), 1837-1846.